» Articles » PMID: 35586659

Mitofilin Mitigates Myocardial Damage in Acute Myocardial Infarction by Regulating Pyroptosis of Cardiomyocytes

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute myocardial infarction (AMI) can lead to sudden cardiac death after prolonged ischemia or heart failure (HF) and impaired left ventricular pump function. However, the underlying mechanism remains largely unknown. The purpose of this study was to investigate the role of mitofilin in alleviating AMI.

Methods: Recombinant adenoviral vectors for mitofilin overexpression or mitofilin knockdown were constructed, respectively. A mouse AMI model was established and the effect of mitofilin on myocardial pyroptosis was examined by detecting the lactate dehydrogenase (LDH) level and inflammatory factors. Moreover, a cellular model of AMI was established by treating cardiomyocytes with hypoxia/reoxygenation (H/R). An enzyme-linked immunosorbent assay (ELISA) and a western blot analysis were used to detect the effect of mitofilin knockdown on the expression of pyroptosis-related factors. Furthermore, the regulatory role of mitofilin in PI3K/AKT pathway was evaluated by the western blot and PI3K inhibitor.

Results: Mitofilin was downregulated in the heart tissue of the AMI mice and H/R induced cardiomyocytes. The overexpression of mitofilin significantly alleviated AMI and reduced pyroptosis-related factors. Meanwhile, in cardiomyocytes, mitofilin knockdown aggravated cellular damages by promoting pyroptosis. Further analysis showed that the anti-pyroptotic effect of mitofilin was dependent on the activation of the PI3K/AKT signaling pathway.

Conclusions: Our study suggests that mitofilin regulates pyroptosis through the PI3K/AKT signaling pathway in cardiomyocytes to ameliorate AMI, which may serve as a therapeutic strategy for the management of AMI.

Citing Articles

Mitofilin-mtDNA Axis Mediates Chronic Lead Exposure-Induced Synaptic Plasticity Impairment of Hippocampal and Cognitive Deficits.

Su L, Hou J, Wang B, Li Y, Huo X, Wang T Biomolecules. 2025; 15(2).

PMID: 40001575 PMC: 11852649. DOI: 10.3390/biom15020272.


Therapeutic Potential of Gasdermin D-Mediated Myocardial Pyroptosis in Ischaemic Heart Disease: Expanding the Paradigm From Bench to Clinical Insights.

Piamsiri C, Maneechote C, Chattipakorn S, Chattipakorn N J Cell Mol Med. 2025; 29(3):e70357.

PMID: 39929748 PMC: 11810530. DOI: 10.1111/jcmm.70357.


Pyroptosis in health and disease: mechanisms, regulation and clinical perspective.

Liu Y, Pan R, Ouyang Y, Gu W, Xiao T, Yang H Signal Transduct Target Ther. 2024; 9(1):245.

PMID: 39300122 PMC: 11413206. DOI: 10.1038/s41392-024-01958-2.


The Role of Pyroptosis in Coronary Heart Disease.

Qiu Y, Meng L, Xing Y, Peng J, Zhou Y, Yu Z Anatol J Cardiol. 2024; .

PMID: 38661060 PMC: 11230581. DOI: 10.14744/AnatolJCardiol.2024.4001.


Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEF.

Alves P, Schauer A, Augstein A, Prieto Jarabo M, Mannel A, Barthel P Cells. 2024; 13(6.

PMID: 38534346 PMC: 10969777. DOI: 10.3390/cells13060502.

References
1.
Yang R, Zhao G, Liang S, Zhang Y, Sun L, Chen H . Mitofilin regulates cytochrome c release during apoptosis by controlling mitochondrial cristae remodeling. Biochem Biophys Res Commun. 2012; 428(1):93-8. DOI: 10.1016/j.bbrc.2012.10.012. View

2.
Zhang Y, Liu X, Bai X, Lin Y, Li Z, Fu J . Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis. J Pineal Res. 2017; 64(2). DOI: 10.1111/jpi.12449. View

3.
Ibanez B, Heusch G, Ovize M, Van de Werf F . Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015; 65(14):1454-71. DOI: 10.1016/j.jacc.2015.02.032. View

4.
Scholwer I, Habib P, Voelz C, Rolfes L, Beyer C, Slowik A . NLRP3 Depletion Fails to Mitigate Inflammation but Restores Diminished Phagocytosis in BV-2 Cells After In Vitro Hypoxia. Mol Neurobiol. 2020; 57(6):2588-2599. DOI: 10.1007/s12035-020-01909-2. View

5.
Russo H, Rathkey J, Boyd-Tressler A, Katsnelson M, Abbott D, Dubyak G . Active Caspase-1 Induces Plasma Membrane Pores That Precede Pyroptotic Lysis and Are Blocked by Lanthanides. J Immunol. 2016; 197(4):1353-67. PMC: 4976007. DOI: 10.4049/jimmunol.1600699. View